Pediatric Neurology
Volume 28, Issue 2 , Pages 130-133 , February 2003

Topiramate effectiveness in Prader-Willi syndrome

  • Sarah A Smathers, BA

      Affiliations

    • Michigan Institute for Neurological Disorders, Farmington Hills, Michigan, USA
    • ,
  • Jacquelyn G Wilson, PharmD, BCPP

      Affiliations

    • Ortho-McNeil Pharmaceutical, Inc., Raritan, New Jersey, USA
    • ,
  • Michael A Nigro, DO, FACN

      Affiliations

    • Michigan Institute for Neurological Disorders, Farmington Hills, Michigan, USA
    • Children’s Hospital of Michigan, Department of Neurology, Detroit, Michigan, USA
    • Wayne State University School of Medicine, Departments of Pediatrics and Neurology, Detroit, Michigan, USA.Presented in part at the American Academy of Neurology 2001 Annual Meeting.
    • Corresponding Author InformationCommunications should be addressed to: Dr. Nigro; Michigan Institute for Neurological Disorders; 28595 Orchard Lake Road; Suite 200; Farmington Hills, Michigan 48334, USA.

Received 18 December 2001 ,Accepted 24 July 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0887-8994(02)00490-3

doi: 10.1016/S0887-8994(02)00490-3

Pediatric Neurology
Volume 28, Issue 2 , Pages 130-133 , February 2003

Article Tools

* Image Usage & Resolution